Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Would you use ceftriaxone for treatment of a deep seated infection such as vertebral osteomyelitis +/- epidural abscess caused by a low risk AmpC producing pathogen?
Assuming no oral antibiotic options, or planning IV course prior to PO switch
Related Questions
What factors do you consider when deciding between monotherapy with an antipseudomonal cephalosporin and combination therapy in ICU patients with Pseudomonas aeruginosa bloodstream infection who are not in septic shock?
How do you or your practice manage young, average-risk patients without structural lung disease referred to you or self-referred for concern of environmental mold exposure?
What specific clinical signs or epidemiological indicators do you prioritize for early identification of Bartonella quintana infection?
Do you routinely continue dual antibiotic coverage or de-escalate to monotherapy based on peritoneal fluid culture sensitivities in patients with relapsing pseudomonas aeruginosa peritoneal dialysis peritonitis after peritoneal catheter removal?
Do you avoid Daptomycin use when there is evidence of septic pulmonary emboli?
Do you recommend treatment of male partners for patients with recurrent bacterial vaginosis?
How do you approach perioperative antimicrobial prophylaxis in patients undergoing reconstructive surgery with myocutaneous flaps whom have recently been treated for active infection?
What is the best approach to determine whether antiviral post-exposure prophylaxis for influenza is appropriate in an elderly immunocompromised patient who has been vaccinated?
Do you routinely use cefdinir for the treatment of common infections diagnosed in the outpatient setting such as CAP, uncomplicated UTIs?
Are there specific organisms other than s. aureus in which you offer indefinite antibiotic suppression in medically treated prosthetic valve endocarditis?